The Dyspnoea, Obstruction, Smoking, Exacerbation (DOSE) index is predictive of mortality in COPD.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Primary Care Respiratory Journal

• Publication date

  2012-07-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.4104/pcrj.2012.00054PMID 22786813PMCID PMC6547953
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Co-Morbidity, Body Mass Index and Quality of Life in COPD Using the Clinical COPD Questionnaire

  2011cited by this paper
• Update in chronic obstructive pulmonary disease: role of antioxidant and metabolizing gene polymorphisms

  2011cited by this paper
• Predictive properties of different multidimensional staging systems in patients with chronic obstructive pulmonary disease

  2011cited by this paper
• Accuracy of Death Certificates in COPD: Analysis from the TORCH Trial

  2010cited by this paper
• How often is diagnosis of COPD confirmed with spirometry?

  2010cited by this paper
• Sex differences in mortality in patients with COPD

  2009cited by this paper
• Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index.

  2009cited by this paper
• Depressive symptoms as predictors of mortality in patients with COPD.

  2009cited by this paper
• Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index.

  2009influential reference
• The modified BODE index: validation with mortality in COPD

  2008cited by this paper
• A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

  2008cited by this paper
• Longitudinal change in the BODE index predicts mortality in severe emphysema.

  2008cited by this paper
• Predictors of Mortality in Patients with Stable COPD

  2008cited by this paper
• Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease.

  2007cited by this paper
• Update in chronic obstructive pulmonary disease 2006.

  2007cited by this paper
• Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

  2007cited by this paper
• COPD heterogeneity: Gender differences in the multidimensional BODE index

  2007cited by this paper
• Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity

  2006cited by this paper
• Potential misclassification of causes of death from COPD

  2006cited by this paper
• Predictors of mortality in patients with emphysema and severe airflow obstruction.

  2006cited by this paper
• The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality

  2005cited by this paper
• The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.

  2004cited by this paper
• Update on chronic obstructive pulmonary disease.

  2004cited by this paper
• Predictors of survival in severe, early onset COPD.

  2004cited by this paper
• Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD.

  2003cited by this paper
• What do chronic obstructive pulmonary disease patients die from? Amultiple cause coding analysis

  2003cited by this paper
• Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD.

  2002cited by this paper
• Mortality after hospitalization for COPD.

  2002cited by this paper
• Global initiative for chronic obstructive lung disease.

  2002cited by this paper
• Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.

  2001cited by this paper
• The impact of COPD on lung health worldwide: epidemiology and incidence.

  2000cited by this paper
• Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease.

  1999cited by this paper
• Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.

  1998cited by this paper
• Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

  1997cited by this paper
• Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force.

  1995cited by this paper
• Lung volumes and forced ventilatory flows

  1993cited by this paper
• Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society.

  1993cited by this paper
• Evaluation of clinical methods for rating dyspnea.

  1988cited by this paper
• Significance of Respiratory Symptoms and the Diagnosis of Chronic Bronchitis in a Working Population

  1959cited by this paper

• Prognostic models for mortality and hospitalisation risk in a contemporary Australian chronic obstructive pulmonary disease cohort.

  2026cites this paper
• Efficacy and Safety of Nebulized Sodium Bicarbonate in Adults with COVID-19 (SODIC): A Randomized, Single-Center, Double-Blinded, Controlled Trial

  2025cites this paper
• Increased Incidence of Chronic Obstructive Pulmonary Disease in Women Due to Long-Term Passive Smoking

  2025cites this paper
• Relation between pulmonary function changes and diaphragmatic ultrasound in patients with idiopathic pulmonary fibrosis

  2025cites this paper
• Development and validation of a novel AI-derived index for predicting COPD medical costs in clinical practice

  2025cites this paper
• Six-minute walking distance is a robust predictor of mortality in stable chronic obstructive pulmonary disease without major comorbidities.

  2025cites this paper
• The Effectiveness and Safety of Chuna Manual Therapy Adjuvant to Western Medicine in Patients with Chronic Obstructive Pulmonary Disease: A Randomized, Single-Blind, Investigator-Initiated, Pilot Trial

  2024cites this paper
• Reducing the risk of death – a possible outcome in COPD patients

  2024cites this paper
• 自主研发的藏四味清肺合剂联合常规治疗对慢性阻塞性肺疾病急性加重期患者的临床疗效和安全性

  2024cites this paper
• Validation of new predictors of mortality and BODE index variants in patients with COPD at moderate altitude

  2024cites this paper
• Study protocol for evaluating the efficacy of early pulmonary rehabilitation combined with an internet-based patient management model in patients with COPD: a practical, multicentre, randomised controlled study from China

  2024cites this paper
• Mortality prevention as the centre of COPD management

  2024cites this paper
• A randomized controlled trial of adjuvant inhalable sodium bicarbonate role in treatment of COVID-19

  2023cites this paper
• Relation between bronchiectasis severity index and chest ultrasound in noncystic fibrosis bronchiectasis patient

  2023cites this paper
• Efficacy of threshold inspiratory muscle trainer versus diaphragmatic plus pursed lip breathing in occupational COPD

  2023cites this paper
• Validation of Clinical COPD Phenotypes for Prognosis of Long-Term Mortality in Swedish and Dutch Cohorts

  2022influential citation
• COPD and comorbidities in the Republic of Moldova

  2022cites this paper
• Dyspnea, Obstruction, Smoking, Exacerbation Index, and Chronic Obstructive Pulmonary Disease Test Score: Correlation in Predicting Outcomes in Patients with Chronic Obstructive Pulmonary Disease Exacerbations

  2022cites this paper
• The Relationship Between Clinical Phenotypes and Global Initiative for Chronic Obstructive Lung Disease (GOLD) Stages/Groups in Patients With Chronic Obstructive Pulmonary Disease

  2022cites this paper
• Promoting Exercise Training Remotely

  2022cites this paper
• COPD_A_277523 1581..1598

  2021cites this paper
• Multidimensional indices in the assessment of chronic obstructive pulmonary disease.

  2021cites this paper
• How to Assess Breathlessness in Chronic Obstructive Pulmonary Disease

  2021cites this paper
• Role of sodium bicarbonate as adjuvant treatment of nonsevere computed tomography-identified COVID-19 pneumonia: A preliminary report

  2021cites this paper
• COPD – do the right thing

  2021cites this paper
• An Introduction to Advanced Lung Disease

  2021cites this paper
• Evaluation of the Clinical Effectiveness of the Salmeterol/Fluticasone Fixed-Dose Combination Delivered via the Elpenhaler® Device in Greek Patients with Chronic Obstructive Pulmonary Disease and Comorbidities: The AEOLOS Study

  2021cites this paper
• Chronic obstructive pulmonary disease and lung cancer: access to palliative care, emergency room visits and hospital deaths

  2021cites this paper
• Prediction of Mortality Using Different COPD Risk Assessments – A 12-Year Follow-Up

  2021cites this paper
• Chronic obstructive pulmonary disease risk assessment tools: is one better than the others?

  2021cites this paper
• COPD_A_329316 3009..3016

  2021influential citation
• Overcoming Therapeutic Inertia to Reduce the Risk of COPD Exacerbations: Four Action Points for Healthcare Professionals

  2021cites this paper
• Association of Guideline-recommended COPD Inhaler Regimenswith Mortality, Respiratory Exacerbations, and Quality of Life: A Secondary Analysis of the Long-Term Oxygen Treatment Trial.

  2020cites this paper
• COPD_A_252709 1495..1505

  2020cites this paper
• Early Predictors of Mortality in Patients with COPD, in Relation to Respiratory and Non-Respiratory Causes of Death – A National Register Study

  2020cites this paper
• The preferences of patients with chronic obstructive pulmonary disease are to discuss palliative care plans with familiar respiratory clinicians, but to delay conversations until their condition deteriorates: A study guided by interpretative phenomenological analysis

  2020cites this paper
• Chronic airflow limitation and its relation to respiratory symptoms among ever-smokers and never-smokers: a cross-sectional study

  2020influential citation
• GOLD POCKET GUIDE 2021 – REFERENCE LIST

  2020cites this paper
• Prognostic ability of the distance‐saturation product in the 6‐minute walk test in patients with chronic obstructive pulmonary disease

  2019cites this paper
• Extracellular adenosine triphosphate is associated with airflow limitation severity and symptoms burden in patients with chronic obstructive pulmonary disease

  2019cites this paper
• Exercise and Sports Pulmonology

  2019cites this paper
• Medical History, Questionnaires and Physical Examination

  2019cites this paper
• Clinical importance of sex differences in dyspnea and its sex related determinants in asthma and COPD patients.

  2019cites this paper
• Sex-related differences in management of Swedish patients with a clinical diagnosis of chronic obstructive pulmonary disease

  2019cites this paper
• Primary care risk stratification in COPD using routinely collected data: a secondary data analysis

  2019cites this paper
• COPD_A_193311 961..969

  2019cites this paper
• External Validation and Recalculation of the CODEX Index in COPD Patients. A 3CIAplus Cohort Study

  2019cites this paper
• Correlation of severity of chronic obstructive pulmonary disease with serum vitamin-D level

  2019cites this paper
• Effects of Chinese medicine on patients with acute exacerbations of COPD: study protocol for a randomized controlled trial

  2019cites this paper
• Clinical validation of a risk scale for serious outcomes among patients with chronic obstructive pulmonary disease managed in the emergency department

  2018cites this paper
• Comparison of Multiple Chronic Obstructive Pulmonary Disease (COPD) Indices in Chinese COPD Patients

  2018cites this paper
• Improving Prediction of Risk of Hospital Admission in Chronic Obstructive Pulmonary Disease: Application of Machine Learning to Telemonitoring Data

  2018cites this paper
• Клинико-функциональный статус пациентов с хронической обструктивной болезнью легких и фибрилляцией предсердий

  2018cites this paper
• COPD Guidelines: Old Gold versus New Gold

  2018cites this paper
• Relaciones de la fragilidad y el agotamiento con el estado de salud en pacientes con EPOC

  2018cites this paper
• Changes in smoking prevalence and cessation support, and factors associated with successful smoking cessation in Swedish patients with asthma and COPD

  2018cites this paper
• Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary

  2017cites this paper
• Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.

  2017cites this paper
• Palliative and end-of-life care conversations in COPD: a systematic literature review

  2017cites this paper
• A study of the clinical profile of 50 patients of COPD with correlation between clinical, radiological and spirometric evaluation

  2017cites this paper
• Commonly Used Patient‐Reported Outcomes Do Not Improve Prediction of COPD Exacerbations: A Multicenter 4½ Year Prospective Cohort Study

  2017cites this paper
• Role of inspiratory capacity on dyspnea evaluation in COPD with or without emphysematous lesions: a pilot study

  2017cites this paper
• Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.

  2017cites this paper
• Demographic, health behavioral, and self‐management abilities associated with disease severity among patients with chronic obstructive pulmonary disease: An exploratory study

  2017cites this paper
• Pulmonary rehabilitation in COPD – available resources and utilization in Swedish primary and secondary care

  2017cites this paper
• Pulmonary rehabilitation in COPD – available resources and utilization in swedish primary and secondary care

  2017cites this paper
• Pulmonary rehabilitation in COPD – available resources and utilization in swedish primary and secondary care

  2017cites this paper
• Ethnic Inequalities in COPD Outcomes: a Register-Based Study in Copenhagen, Denmark

  2017cites this paper
• Factors influencing pharmacological treatment in COPD: a comparison of 2005 and 2014

  2017cites this paper
• Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report

  2017cites this paper
• Comparison of the COPD Assessment Test (CAT) and the Clinical COPD Questionnaire (CCQ) in a Clinical Population

  2016cites this paper
• Prediction and prevention of exacerbations and mortality in patients with COPD

  2016cites this paper
• Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets

  2016cites this paper
• Change in health status in COPD: a seven-year follow-up cohort study

  2016cites this paper
• Predikcija ishoda skrbi bolesnika s kroničnom opstruktivnom plućnom bolesti u obiteljskoj medicini

  2016cites this paper
• Body mass index, airflow obstruction and dyspnea and body mass index, airflow obstruction, dyspnea scores, age and pack years-predictive properties of new multidimensional prognostic indices of chronic obstructive pulmonary disease in primary care

  2016cites this paper
• External validation of multidimensional prognostic indices (ADO, BODEx and DOSE) in a primary care international cohort (PROEPOC/COPD cohort)

  2016cites this paper
• Health-related quality of life in a nationwide cohort of patients with COPD related to other characteristics

  2016cites this paper
• Prognostic assessment of mortality and hospitalizations of outpatients with advanced chronic obstructive pulmonary disease. Usefulness of the CODEX index.

  2015cites this paper
• The Pneumonia Severity Index as a Predictor of In-Hospital Mortality in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

  2015cites this paper
• Prognostic assessment of mortality and hospitalizations of outpatients with advanced chronic obstructive pulmonary disease. Usefulness of the CODEX index.

  2015cites this paper
• ALAT-2014 Chronic Obstructive Pulmonary Disease (COPD) Clinical Practice Guidelines: questions and answers.

  2015cites this paper
• Fatigue Affects Health Status and Predicts Mortality Among Subjects with COPD: Report from the Population-Based OLIN COPD Study

  2015cites this paper
• COPD and its comorbidities: Impact, measurement and mechanisms

  2015cites this paper
• Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD.

  2015cites this paper
• ALAT-2014 Chronic Obstructive Pulmonary Disease (COPD) Clinical Practice Guidelines: questions and answers.

  2015cites this paper
• Clinical characteristics associated with adverse events in patients with exacerbation of chronic obstructive pulmonary disease: a prospective cohort study

  2014cites this paper
• Medical Utilization and Cost in Patients with Overlap Syndrome of Chronic Obstructive Pulmonary Disease and Asthma

  2014cites this paper
• On Goldilocks, care coordination, and palliative care: making it ‘just right’

  2014cites this paper
• Guía española de la EPOC (GesEPOC). Actualización 2014

  2014cites this paper
• Short- and medium-term prognosis in patients hospitalized for COPD exacerbation: the CODEX index.

  2014cites this paper
• Spanish guideline for COPD (GesEPOC). Update 2014.

  2014cites this paper
• National cohort data from Sweden to the National COPD audit in England and Wales: grand designs for quality improvement

  2014cites this paper
• Primary Care COPD Patients Compared with Large Pharmaceutically-Sponsored COPD Studies: An UNLOCK Validation Study

  2014cites this paper
• Spanish Guideline for COPD (GesEPOC). Update 2014

  2014cites this paper
• Reducing the Readmission Burden of COPD: A Focused Review of Recent Interventions

  2014cites this paper
• Examination of the contribution of mindfulness and catastrophising to the presence of anxiety and frequency of COPD related hospital admissions in COPD patients.

  2014cites this paper
• Correction: Primary Care COPD Patients Compared with Large Pharmaceutically-Sponsored COPD Studies: An UNLOCK Validation Study

  2014cites this paper
• A Better Way to Evaluate Remote Monitoring Programs in Chronic Disease Care: Receiver Operating Characteristic Analysis

  2014cites this paper
• The potential interaction of MARCKS-related peptide and diltiazem on acrolein-induced airway mucus hypersecretion in rats.

  2013cites this paper